Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice
- PMID: 15364435
- DOI: 10.1016/j.vaccine.2004.04.012
Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice
Abstract
In this study, the haemolytic activities of Panax notoginseng saponins (PNS) and its adjuvant potentials on the cellular and humoral immune responses of ICR mice against ovalbumin (OVA) were evaluated. We determined the haemolytic activity of PNS using 0.5% rabbit red blood cell. PNS showed a slight haemolytic effect, with its haemolytic percents being 11.59 and 3.60% at the concentrations of 500 and 250 microg/ml, respectively. Furthermore, the adjuvant potential of PNS at three dose levels on the cellular and humoral immune responses of ICR mice against ovalbumin were investigated. ICR mice were immunized subcutaneously with OVA 100 microg alone or with OVA 100 microg dissolved in saline containing aluminum hydroxide gel (Alum) (200 microg), Quil A (10 and 50 microg) or PNS (50, 100 or 200 microg) on days 1 and 15. Two weeks later (day 28), concanavalin A (Con A)-, pokeweed (PWM)- and OVA-stimulated splenocyte proliferation and OVA-specific antibodies in serum were measured. PNS significantly enhanced the Con A-, PWM-, and OVA-induced splenocyte proliferation in the OVA-immunized mice at a dose of 100 microg (P < 0.05 or P < 0.025). OVA-specific IgG, IgG1 and IgG2b antibody levels in serum were significantly enhanced by PNS compared with OVA control group (P < 0.025). Moreover, enhancing effect of PNS on the OVA-specific IgG2b antibody responses to OVA in mice were more significant than that of Quil A (P < 0.025). In conclusion, the results suggest that PNS could be safely used as adjuvant with low or non-haemolytic effect.
Similar articles
-
Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice.Vaccine. 2006 Feb 27;24(9):1324-31. doi: 10.1016/j.vaccine.2005.09.030. Epub 2005 Sep 23. Vaccine. 2006. PMID: 16214270
-
A promising balanced Th1 and Th2 directing immunological adjuvant, saponins from the root of Platycodon grandiflorum.Vaccine. 2008 Jul 23;26(31):3937-45. doi: 10.1016/j.vaccine.2008.01.061. Epub 2008 May 20. Vaccine. 2008. PMID: 18547688
-
Haemolytic activities and immunologic adjuvant effect of Panax notoginseng saponins.Acta Pharmacol Sin. 2003 Nov;24(11):1150-4. Acta Pharmacol Sin. 2003. PMID: 14627501
-
Saponins as vaccine adjuvants.Crit Rev Ther Drug Carrier Syst. 1996;13(1-2):1-55. Crit Rev Ther Drug Carrier Syst. 1996. PMID: 8853958 Review.
-
[Balance between cardiovascular pharmacological and hemolytic effects of saponins of Panax notogenseng].Zhongguo Zhong Yao Za Zhi. 2016 Mar;41(5):818-822. doi: 10.4268/cjcmm20160510. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28875633 Review. Chinese.
Cited by
-
Effects of Korean Red Ginseng and HAART on vif Gene in 10 Long-Term Slow Progressors over 20 Years: High Frequency of Deletions and G-to-A Hypermutation.Evid Based Complement Alternat Med. 2013;2013:871648. doi: 10.1155/2013/871648. Epub 2013 Nov 14. Evid Based Complement Alternat Med. 2013. PMID: 24319487 Free PMC article.
-
Ginseng Polysaccharide Enhances the Humoral and Cellular Immune Responses to SARS-CoV-2 RBD Protein Subunit Vaccines.Vaccines (Basel). 2023 Dec 8;11(12):1833. doi: 10.3390/vaccines11121833. Vaccines (Basel). 2023. PMID: 38140237 Free PMC article.
-
Role of Bioactive Constituents of Panax notoginseng in the Modulation of Tumorigenesis: A Potential Review for the Treatment of Cancer.Front Pharmacol. 2021 Oct 27;12:738914. doi: 10.3389/fphar.2021.738914. eCollection 2021. Front Pharmacol. 2021. PMID: 34776959 Free PMC article. Review.
-
Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.Aging Dis. 2017 Dec 1;8(6):721-739. doi: 10.14336/AD.2017.0724. eCollection 2017 Dec. Aging Dis. 2017. PMID: 29344413 Free PMC article. Review.
-
Low-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horses.Can J Vet Res. 2007 Jul;71(3):213-7. Can J Vet Res. 2007. PMID: 17695597 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources